Biblio Discovery — Demo Discovery Service

19 results for "Assa Sittner"

Showing 1–19 · 2.74 seconds · RSS

  1. Journal Article Full text

    Toxin-Independent Virulence of Bacillus anthracis in Rabbits

    Haim Levy; Itai Glinert; Shay Weiss et al.

    PLoS ONE, Vol. 9 No. 1 · 2014 · English · PLOS Scopus

    The accepted paradigm states that anthrax is both an invasive and toxinogenic disease and that the toxins play a major role in pathogenicity. In the guinea pig (GP) model we have previously shown that deletion of all three toxin components results in a relatively moderate attenuation in virulence…

    Also available at: DOAJ

  2. Journal Article Full text

    The Central Nervous System as Target of Bacillus anthracis Toxin Independent Virulence in Rabbits and Guinea Pigs

    Haim Levy; Itai Glinert; Shay Weiss et al.

    PLoS ONE, Vol. 9 No. 11 · 2014 · English · PLOS Scopus

    Infection of the central nervous system is considered a complication of Anthrax and was reported in humans and non-human primates. Previously we have reported that Bacillus anthracis possesses a toxin-independent virulent trait that, like the toxins, is regulated by the major virulence regulator…

    Also available at: DOAJ

  3. Journal Article Full text

    Efficacy of Doxycycline as Monotherapy or in Combination with Levofloxacin in Treating Late-Stage Systemic Anthrax in Non-Human Primates

    Amir Ben-Shmuel; Assa Sittner; Itai Glinert et al.

    International Journal of Translational Medicine, Vol. 6 No. 3 · 2026 · English · DOAJ Scopus

    Background: Bacillus anthracis spores pose a major biosecurity threat, in light of their use in several documented bioterror attacks and the fact that it was weaponized. The absence of specific and accurate treatment instructions in the 2001 anthrax letter attacks and the poor prognosis of patients…

  4. Journal Article Full text

    Closing the Gaps: Testing the Efficacy of Carbapenem and Cephalosporin Treatments of Late-Stage Anthrax in Rabbits

    Assa Sittner; Elad Bar-David; Itai Glinert et al.

    Pathogens, Vol. 13 No. 11 · 2024 · English · DOAJ Scopus

    Anthrax is a fatal zoonotic disease caused by exposure to Bacillus anthracis spores. The CDC’s guidelines divide anthrax treatment into three categories according to disease progression: post-exposure prophylaxis (PEP), systemic, and systemic with a suspicion of CNS infection. While the prognosis…

  5. Journal Article Full text

    Pathology of wild-type and toxin-independent Bacillus anthracis meningitis in rabbits

    Assa Sittner; Elad Bar-David; Itai Glinert et al.

    PLOS ONE, Vol. 12 No. 10 · 2017 · English · PLOS Scopus

    Hemorrhagic meningitis is considered a complication of anthrax and was reported in about 50% of deadly cases in humans and non-human primates (NHP). Recently we demonstrated in Guinea pigs and rabbits that 100% of the B. anthracis-infected animals presented histopathology of meningitis at the time…

    Also available at: DOAJ

  6. Journal Article Full text

    Using old antibiotics to treat ancient bacterium—β-lactams for Bacillus anthracis meningitis

    Assa Sittner; Amir Ben-Shmuel; Itai Glinert et al.

    PLOS ONE, Vol. 15 No. 2 · 2020 · English · PLOS Scopus

    As Bacillus anthracis spores pose a proven bio-terror risk, the treatment focus has shifted from exposed populations to anthrax patients and the need for effective antibiotic treatment protocols increases. The CDC recommends carbapenems and Linezolid (oxazolidinone), for the treatment of anthrax…

    Also available at: DOAJ

  7. Journal Article Full text

    Alternate atxA and acpA dependent response of Bacillus anthracis to serum, HCO 3 - and CO 2

    Itai Glinert; Elad Bar-David; Amir Ben-Shmuel et al.

    PLOS ONE, Vol. 18 No. 2 · 2023 · English · PLOS Scopus

    Bacillus anthracis overcomes host immune responses by producing capsule and secreting toxins. Production of these virulence factors in response to entering the host environment was shown to be regulated by atxA, the major virulence regulator, known to be activated by HCO3- and CO2. While toxin…

    Also available at: DOAJ, DOAJ

  8. Journal Article Full text

    Infection with a Nonencapsulated Bacillus anthracis Strain in Rabbits—The Role of Bacterial Adhesion and the Potential for a Safe Live Attenuated Vaccine

    Itai Glinert; Shay Weiss; Assa Sittner et al.

    Toxins, Vol. 10 No. 12 · 2018 · English · DOAJ Scopus

    Nonencapsulated (∆pXO2) Bacillus anthracis strains are commonly used as vaccines and for anthrax research, mainly in the mouse model. Previously, we demonstrated that the infection of rabbits, intranasally or subcutaneously, with the spores of a fully virulent strain results in the systemic…

  9. Journal Article Full text

    Epitope Binning of Novel Monoclonal Anti F1 and Anti LcrV Antibodies and Their Application in a Simple, Short, HTRF Test for Clinical Plague Detection

    Adva Mechaly; Einat B. Vitner; Yinon Levy et al.

    Pathogens, Vol. 10 No. 3 · 2021 · English · DOAJ Scopus

    Mouse monoclonal antibodies were raised against plague disease biomarkers: the bacterial capsular protein fraction 1 (F1) and the low-calcium response—LcrV virulence factor (Vag). A novel tandem assay, employing BioLayer Interferometry (BLI), enabled the isolation of antibodies against four…

  10. Journal Article Full text

    Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection

    Chaja Katzman; Tomer Israely; Sharon Melamed et al.

    Viruses, Vol. 14 No. 1 · 2021 · English · DOAJ Scopus

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a severe global pandemic. Mice models are essential to investigate infection pathology, antiviral drugs, and vaccine development. However, wild-type mice lack the human angiotensin-converting enzyme 2 (hACE2) that mediates…

  11. Journal Article

    A Serological Snapshot of COVID-19 Initial Stages in Israel by a 6-Plex Antigen Array

    Morly Fisher; Haim Levy; Ella Fatelevich et al.

    Microbiology Spectrum, Vol. 9 No. 2 · 2021 · English · DOAJ Scopus

    ABSTRACT The first case of SARS-CoV-2 was discovered in Israel in late February 2020. Three major outbreaks followed, resulting in over 800,000 cases and over 6,000 deaths by April 2021. Our aim was characterization of a serological snapshot of Israeli patients and healthy adults in the early…

  12. Journal Article Full text

    A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge

    Yfat Yahalom-Ronen; Hadas Tamir; Sharon Melamed et al.

    Nature Communications · 2020 · English · OpenAlex Scopus

    The COVID-19 pandemic caused by SARS-CoV-2 imposes an urgent need for rapid development of an efficient and cost-effective vaccine, suitable for mass immunization. Here, we show the development of a replication competent recombinant VSV-∆G-spike vaccine, in which the glycoprotein of VSV is replaced…

    Also available at: DOAJ